Leticia Cano
President
Biomarker Profile Corporation
USA
Biography
Leticia Cano identified a native citrullinated autoantigen for rheumatoid arthritis for her Ph.D. dissertation. She did her postdoctoral training in the laboratory of Hank Fales at the National Institutes of Health, where she identified candidate biomarkers for Dermatomyositis, Juvenile Idiopathic Arthritis Systemic Lupus Erythematosis. As Founder and President of Biomarker Profiles Corporation, she is interested in developing methods to increase the speed of biomarker discovery.
Research Interest
she is interested in developing methods to increase the speed of biomarker discovery.